[go: up one dir, main page]

ITMI982222A0 - Composizioni farmaceutiche orali contenenti buprenorfina - Google Patents

Composizioni farmaceutiche orali contenenti buprenorfina

Info

Publication number
ITMI982222A0
ITMI982222A0 IT98MI002222A ITMI982222A ITMI982222A0 IT MI982222 A0 ITMI982222 A0 IT MI982222A0 IT 98MI002222 A IT98MI002222 A IT 98MI002222A IT MI982222 A ITMI982222 A IT MI982222A IT MI982222 A0 ITMI982222 A0 IT MI982222A0
Authority
IT
Italy
Prior art keywords
buprenerphine
pharmaceutical compositions
compositions containing
oral pharmaceutical
oral
Prior art date
Application number
IT98MI002222A
Other languages
English (en)
Inventor
Mauro Valenti
Original Assignee
Formenti Farmaceutici Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Formenti Farmaceutici Spa filed Critical Formenti Farmaceutici Spa
Publication of ITMI982222A0 publication Critical patent/ITMI982222A0/it
Priority to IT1998MI002222A priority Critical patent/IT1302682B1/it
Priority to DE69923336T priority patent/DE69923336T2/de
Priority to ES99950690T priority patent/ES2237165T3/es
Priority to HU0103924A priority patent/HU226166B1/hu
Priority to PT99950690T priority patent/PT1121127E/pt
Priority to EP99950690A priority patent/EP1121127B1/en
Priority to US09/807,216 priority patent/US6365596B1/en
Priority to SI9930736T priority patent/SI1121127T1/xx
Priority to DK99950690T priority patent/DK1121127T3/da
Priority to JP2000576853A priority patent/JP2002527480A/ja
Priority to AU63371/99A priority patent/AU752449B2/en
Priority to CA002347195A priority patent/CA2347195C/en
Priority to NZ511085A priority patent/NZ511085A/xx
Priority to PCT/EP1999/007595 priority patent/WO2000023079A1/en
Priority to AT99950690T priority patent/ATE287264T1/de
Publication of ITMI982222A1 publication Critical patent/ITMI982222A1/it
Application granted granted Critical
Publication of IT1302682B1 publication Critical patent/IT1302682B1/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
IT1998MI002222A 1998-10-16 1998-10-16 Composizioni farmaceutiche orali contenenti buprenorfina IT1302682B1 (it)

Priority Applications (15)

Application Number Priority Date Filing Date Title
IT1998MI002222A IT1302682B1 (it) 1998-10-16 1998-10-16 Composizioni farmaceutiche orali contenenti buprenorfina
DK99950690T DK1121127T3 (da) 1998-10-16 1999-10-11 Orale farmaceutiske sammensætninger, som indeholder buprenorphin
AU63371/99A AU752449B2 (en) 1998-10-16 1999-10-11 Oral pharmaceutical compositions containing buprenorphin
HU0103924A HU226166B1 (en) 1998-10-16 1999-10-11 Oral pharmaceutical compositions containing buprenorphin
PT99950690T PT1121127E (pt) 1998-10-16 1999-10-11 Composicoes farmaceuticas orais contendo buprenorfina
EP99950690A EP1121127B1 (en) 1998-10-16 1999-10-11 Oral pharmaceutical compositions containing buprenorphin
US09/807,216 US6365596B1 (en) 1998-10-16 1999-10-11 Oral pharmaceutical compositions containing buprenorphin
SI9930736T SI1121127T1 (en) 1998-10-16 1999-10-11 Oral pharmaceutical compositions containing buprenorphin
DE69923336T DE69923336T2 (de) 1998-10-16 1999-10-11 Oral anzuwendende buprenorphinhaltige arzneimittel
JP2000576853A JP2002527480A (ja) 1998-10-16 1999-10-11 ブプレノルフィンを含有する経口の製薬学的組成物
ES99950690T ES2237165T3 (es) 1998-10-16 1999-10-11 Composiciones farmaceuticas orales que contienen buprenorfina.
CA002347195A CA2347195C (en) 1998-10-16 1999-10-11 Oral pharmaceutical compositions containing buprenorphin
NZ511085A NZ511085A (en) 1998-10-16 1999-10-11 Oral pharmaceutical compositions containing buprenorphin
PCT/EP1999/007595 WO2000023079A1 (en) 1998-10-16 1999-10-11 Oral pharmaceutical compositions containing buprenorphin
AT99950690T ATE287264T1 (de) 1998-10-16 1999-10-11 Oral anzuwendende buprenorphinhaltige arzneimittel

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT1998MI002222A IT1302682B1 (it) 1998-10-16 1998-10-16 Composizioni farmaceutiche orali contenenti buprenorfina

Publications (3)

Publication Number Publication Date
ITMI982222A0 true ITMI982222A0 (it) 1998-10-16
ITMI982222A1 ITMI982222A1 (it) 2000-04-16
IT1302682B1 IT1302682B1 (it) 2000-09-29

Family

ID=11380880

Family Applications (1)

Application Number Title Priority Date Filing Date
IT1998MI002222A IT1302682B1 (it) 1998-10-16 1998-10-16 Composizioni farmaceutiche orali contenenti buprenorfina

Country Status (15)

Country Link
US (1) US6365596B1 (it)
EP (1) EP1121127B1 (it)
JP (1) JP2002527480A (it)
AT (1) ATE287264T1 (it)
AU (1) AU752449B2 (it)
CA (1) CA2347195C (it)
DE (1) DE69923336T2 (it)
DK (1) DK1121127T3 (it)
ES (1) ES2237165T3 (it)
HU (1) HU226166B1 (it)
IT (1) IT1302682B1 (it)
NZ (1) NZ511085A (it)
PT (1) PT1121127E (it)
SI (1) SI1121127T1 (it)
WO (1) WO2000023079A1 (it)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002242705B2 (en) * 2001-02-16 2006-08-24 Gruenenthal Gmbh Utilization of buprenorphine in urinary incontinence therapy
US20140271788A1 (en) 2013-03-15 2014-09-18 Monosol Rx, Llc Sublingual and buccal film compositions
MXPA06011871A (es) 2004-04-15 2007-10-08 Chiasma Inc Composiciones capaces de facilitar la penetracion a traves de una barrera biologica.
ATE412404T1 (de) * 2004-06-02 2008-11-15 Galephar M F Stabile orale pharmazeutische zusammensetzungen von buprenorphin und salz davon
AU2006316607A1 (en) * 2005-11-21 2007-05-31 Schering-Plough Pty. Limited Pharmaceutical compositions comprising buprenorphine
EP1897543A1 (en) 2006-08-30 2008-03-12 Euro-Celtique S.A. Buprenorphine- wafer for drug substitution therapy
US20090270438A1 (en) * 2006-10-18 2009-10-29 Clive Booles Novel compositions and formulations
US20090082383A1 (en) * 2007-09-26 2009-03-26 Protia, Llc Deuterium-enriched buprenorphine
RU2678833C2 (ru) 2008-09-17 2019-02-04 Киазма Инк. Фармацевтические композиции и соответствующие способы доставки
GB2469792A (en) * 2009-04-23 2010-11-03 Calvin John Ross Oil-based pharmaceutical formulation for sublingual delivery
RS53995B1 (sr) 2011-09-19 2015-10-30 Orexo Ab Nove farmaceutske kompozicije, otporne na zloupotrebu, za tretman zavisnosti od opioida
US9867818B2 (en) 2013-09-10 2018-01-16 Insys Development Company, Inc. Sublingual buprenorphine spray
US9918981B2 (en) 2013-09-10 2018-03-20 Insys Development Company, Inc. Liquid buprenorphine formulations
US9839611B2 (en) 2013-09-10 2017-12-12 Insys Development Company, Inc. Sublingual buprenorphine spray
CA2923811C (en) 2013-09-10 2021-07-27 Insys Pharma, Inc. Sublingual buprenorphine spray
JP2017519803A (ja) 2014-07-08 2017-07-20 インシス・ファーマ・インコーポレーテッド 舌下ナロキソンスプレー
US10617686B2 (en) 2014-07-08 2020-04-14 Hikma Pharmaceuticals Usa Inc. Liquid naloxone spray
US10722510B2 (en) 2014-07-08 2020-07-28 Hikma Pharmaceuticals Usa Inc. Liquid naloxone spray
HUE071943T2 (hu) 2015-02-03 2025-10-28 Amryt Endo Inc Akromegália kezelése oktreotid orális alkalmazásával
AU2019209416A1 (en) 2018-01-22 2020-07-30 Foresee Pharmaceuticals Co., Ltd. Pharmaceutical composition for sustained release delivery of buprenorphine
US11141457B1 (en) 2020-12-28 2021-10-12 Amryt Endo, Inc. Oral octreotide therapy and contraceptive methods

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4605671A (en) * 1984-09-28 1986-08-12 American Home Products Corporation Parenteral formulation
JPH03275622A (ja) * 1990-03-26 1991-12-06 Teisan Seiyaku Kk マレイン酸トリメブチンを含有する経口固形製剤
JPH08295637A (ja) * 1995-04-27 1996-11-12 Green Cross Corp:The 口腔部局所投与剤
AU2059297A (en) * 1996-03-12 1997-10-01 Alza Corporation Composition and dosage form comprising opioid antagonist
JP3687025B2 (ja) * 1998-06-04 2005-08-24 東和薬品株式会社 安定なマレイン酸エナラプリル錠剤

Also Published As

Publication number Publication date
HU226166B1 (en) 2008-05-28
NZ511085A (en) 2002-10-25
EP1121127A1 (en) 2001-08-08
WO2000023079A1 (en) 2000-04-27
CA2347195C (en) 2008-03-18
ES2237165T3 (es) 2005-07-16
ITMI982222A1 (it) 2000-04-16
SI1121127T1 (en) 2005-06-30
JP2002527480A (ja) 2002-08-27
DE69923336D1 (de) 2005-02-24
CA2347195A1 (en) 2000-04-27
EP1121127B1 (en) 2005-01-19
HUP0103924A3 (en) 2003-05-28
DE69923336T2 (de) 2005-05-25
HUP0103924A2 (hu) 2002-02-28
IT1302682B1 (it) 2000-09-29
PT1121127E (pt) 2005-03-31
AU6337199A (en) 2000-05-08
ATE287264T1 (de) 2005-02-15
US6365596B1 (en) 2002-04-02
AU752449B2 (en) 2002-09-19
DK1121127T3 (da) 2005-05-02

Similar Documents

Publication Publication Date Title
DE69924999D1 (de) Lipasehemmer enthaltende pharmazeutische zusammensetzungen
EA199900373A3 (ru) Фармацевтические композиции
ID26720A (id) Komposisi oral
ID27415A (id) Komposisi farmaseutik
NO20005913D0 (no) Legemiddelsammensetning
DE69822172D1 (de) Levosimendanhaltige oral anzuwendende arzneizusammensetzungen
ID20233A (id) Komposisi oral
DK0936913T3 (da) Oralt farmaceutisk præparat indeholdende ibandronat
NO20020208L (no) Flytende sammensetninger for oral administrasjon
FR2775596B1 (fr) Nouvelles compositions pharmaceutiques
ID19097A (id) Komposisi-komposisi oral
PT1242087E (pt) Composicoes farmaceuticas
ID29262A (id) Komposisi farmasi
ITMI982222A0 (it) Composizioni farmaceutiche orali contenenti buprenorfina
ID27201A (id) Komposisi farmasi
BR9510467A (pt) Composições orais
BR9510307A (pt) Composições orais
PT1239832E (pt) Composicoes farmaceuticas
ID20466A (id) Komposisi oral
IS5184A (is) Lyfjasamsetningar
EE9900206A (et) N-sulfonüülindoliiniderivaate sisaldavad farmatseutilised kompositsioonid
PT1227817E (pt) Composicao farmaceutica aquosa contendo ciclesonida
PT986537E (pt) Novos compostos heteroetinilenos e composicoes farmaceuticas e cosmeticas contendo-os
DE69901022D1 (de) Mundpflegezusammensetzungen
EE200000330A (et) Farmatseutilised kompositsioonid

Legal Events

Date Code Title Description
0001 Granted